financial trading


SpaceX just kicked off this weekend’s rocket launch double feature.

The private space company — headed by Tesla (TSLA) CEO Elon Musk — blasted a communications satellite into orbit from Kennedy Space Center in Cape Canaveral, Florida.

SpaceX is slated to make another launch on Sunday.

Friday’s mission marked the second time SpaceX has put a used, first-stage rocket booster back into space. The booster was previously used in a January mission.


SpaceX wants to reuse its rockets in order to drastically reduce the cost of a single launch. Recovering, refurbishing and then re-flying an orbital-class rocket is a feat no other company has accomplished. And completing a second mission with a used rocket will signal to SpaceX’s customers that it can pull off the maneuver safely. That could mean more, cheaper launches with pre-flown rocket boosters.

SpaceX’s playbook: Make history, then make more history

Musk says he wants to event ually reduce the cost of a launch by a factor of 100.

financial trading: NVIDIA Corporation(NVDA)


Advisors’ Opinion:

  • [By Diane Alter]

    However, good news for AMD likely means bad news for NVIDIA Corp. (Nasdaq: NVDA)…

    You see, Intel and NVIDIA have a cross-licensing agreement that gives Intel access to some NVIDIA patents. The agreement expires early next year, and there has been no news of a renewal.

  • [By Kumar Abhishek]

    Short interest in NVIDIA Corporation (NSDQ:NVDA) stock saw a drastic fall in the latest round of reporting, indicating a decline in bearish sentiment around NVIDIA stock. This is thefirst time since theend of July that short interest in NVIDIA stock has seen any significant decline. The number of shorted shares fell by more than 23% from 71.4 million shares to 54.8 million shares, with short interest coming in at 10.8% of the float and days to cover at 2 days. Short interest has followed the stock price with the number of shorted shares shooting up from 44.44 million shares at the end of July to 71.4 million in mid-December, a rise of more than 60%.

  • [By Casey Wilson]

    Nvidia Corp. (Nasdaq: NVDA) has long been a market leader in the graphics card industry. Over the past year, the company managed to grow its market share by 39% – while its stock soared 206%.

  • [By Nicholas Rossolillo]

    Robocar is a completely autonomous racer, devoid of any cockpit or on-board human controls. Instead, an expansive array of radar and cameras will run the show. The powertrain is all-electric and can reach speeds in excess of 200 miles per hour. The Robocar has a number of sponsors, includingtire maker Michelin, electric vehicle technologist Charge, and chipmaker Nvidia (NASDAQ:NVDA).

financial trading: Alaska Air Group, Inc.(ALK)


Advisors’ Opinion:

  • [By Ben Levisohn]

    Alaska Air Group (ALK) has advanced 1.3% to $94.55 after getting upgraded to Buy from Hold at Stifel.

    Shake Shack (SHAK) has risen 1.7% to $33 after getting upgraded to Neutral from Underperform at Wedbush.

  • [By Adam Levine-Weinberg]

    While Southwest Airlines achieved the best score overall, Alaska Air (NYSE:ALK) received top marks among traditional carriers. This was its 10th consecutive victory in the traditional carrier segment.

  • [By Adam Levine-Weinberg]

    To meet this condition, Delta and Aeromexico agreed to divest up to 24 slot pairs at Mexico City International Airport. Now, the three largest low-fare airlines in the U.S. — Southwest Airlines (NYSE:LUV), Alaska Air (NYSE:ALK), and JetBlue Airways (NASDAQ:JBLU) — are close to being cleared for expansion in Mexico City.

  • [By Ben Levisohn]

    While the airline stocks have pulled back recently, coming off a choppy 1Q17, we have In-Line ratings on the Big 3 (American Airlines [AAL], Delta Air Lines [DAL] and United Continental [UAL]), as well as on Alaska Air Group (ALK)…

  • [By Adam Levine-Weinberg]

    It’s been clear from the beginning that Alaska Air’s (NYSE:ALK) acquisition of Virgin America was bad news for United Continental (NYSE:UAL). Alaska Air’s management viewed the deal as a springboard for growth in California — especially in the Bay Area. Meanwhile, United is the dominant airline in San Francisco.

  • [By Paul Ausick]

    The best airline, overall, was Alaska Air Group Inc. (NYSE: ALK). Other category winners were Spirit Airlines Co. (NASDAQ: SAVE), which was ranked cheapest; Alaska rated most reliable; JetBlue Airways Inc. (NASDAQ: JBLU) was most comfortable; best for pets was Alaska; and the airline receiving the fewest complaints was Southwest Airlines Co. (NYSE: LUV).

financial trading: Carter's, Inc.(CRI)


Advisors’ Opinion:

  • [By Ben Levisohn]

    After running through their scenarios,Boruchow comes up with five losers from Trump’s tax plans: Carters (CRI), Urban Outfitters (URBN), Under Armour (UA), Fossil Group (FOSL) and Gap (GPS). He explains why:

financial trading: Ellie Mae, Inc.(ELLI)

Advisors’ Opinion:

  • [By Jason Hall, Brian Stoffel, and Brian Feroldi]

    With that idea in mind, we asked three of our top contributors to write about a stock they see as being a bargain today, and they gave us mortgage industry software lynchpinEllie Mae Inc(NYSE:ELLI), real estate holding companyStore Capital Corp(NYSE:STOR), and steelmaker extraordinaireNucor Corporation(NYSE:NUE).

  • [By Lee Jackson]

    These companies also reported insider selling last week:Corcept Therapeutics Inc. (NASDAQ: CORT), Customers Bancorp Inc. (NYSE: CUBI), Ellie Mae Inc. (NYSE: ELLI), Fiserv Inc. (NASDAQ: FISV) and Ulta Beauty Inc. (NASDAQ: ULTA).

  • [By Jason Moser]

     Not intimidated by the Fed’s 25-basis-point rate hike in December, Jason chose Ellie Mae (ELLI), a company with a leading cloud productthat facilitates and streamlines the mortgage originations process.

    “Its primary offering, Encompass, is a cloud-based one-stop shop for mortgage originators, allowing them to manage the loan process from start to finish,” Moser says. And by streamlining the process, Ellie Mae’s Encompass “increases efficiency and loan quality, reduces documentation errors, and helps keep everyone out of regulatory trouble.”


    With trailing revenues just below $250 million, Moser pegs the market opportunity as a $5 billion pie, and thinks ELLI will prove to be one of the best stocks to buy for 2016.

financial trading: Critical Elements Corporation (CRECF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    ILC reminds me of Critical Elements [TSXV:CRE] (OTCQX:CRECF) having five projects (CRE has 11), and also of Galaxy Resources (ASX:GXY) (OTCPK:GALXF) by being diversified across brine and spodumene and across three continents. Also some similarity with Neo Lithium’s (OTC:NTTHF) [TSXV:NLC] early stage Argentinean brine project which I recently wrote about here. However, ILC trades at a much smaller market cap of US$8m to that of Critical Elements (US$85m) or Galaxy Resources (US$724m). This is partly due to ILC giving away significant percentages of their projects, and because they are still in the early stages of development.

financial trading: Cleveland BioLabs, Inc.(CBLI)


Advisors’ Opinion:

  • [By Alex McGuire]

    You see, penny stocks are attractive because they can offer double-digit or even triple-digit returns in a very short time. For example, Cleveland BioLabs Inc. (Nasdaq: CBLI) skyrocketed from $1.56 at the Thursday, April 13, close to $5.10 on Wednesday, April 19. That’s a stunning 227% return in just three sessions (the markets were closed that Friday).

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6% Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7% Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2% Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3% Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7% Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9% Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3% Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9% Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4% Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Lisa Levin]

    In trading on Tuesday, healthcare shares fell by 0.98 percent. Meanwhile, top losers in the sector included Cleveland BioLabs, Inc. (NASDAQ: CBLI), down 25 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI), down 8 percent.